Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
VWS1
MCID: VND007
MIFTS: 55

Van Der Woude Syndrome 1 (VWS1)

Categories: Genetic diseases, Rare diseases, Fetal diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Van Der Woude Syndrome 1

About this section

MalaCards integrated aliases for Van Der Woude Syndrome 1:

Name: Van Der Woude Syndrome 1 57 75
Van Der Woude Syndrome 57 12 76 53 25 59 29 13 55 6 44 15 73
Lip-Pit Syndrome 57 12 25 59 75
Cleft Lip and/or Palate with Mucous Cysts of Lower Lip 57 53 25 75
Vdws 57 53 25 75
Lps 57 53 75
Vws 53 25 59
Vws1 57 75
Myopathy, Actin, Congenital, with Excess of Thin Myofilaments 44
Cleft Lip/palate with Mucous Cysts of Lower Lip 59
Van Der Woude Syndrome, Type 1 40
Lip-Pit Syndrome; Lps; Pit 57
Lip Pit Syndrome 53
Lip Pit 29
Pit 75

Characteristics:

Orphanet epidemiological data:

59
van der woude syndrome
Inheritance: Autosomal dominant,Not applicable; Prevalence: 1-9/100000 (Finland),1-9/100000 (France),1-9/100000 (Australia),1-9/1000000 (Taiwan, Province of China),1-9/1000000 (United States),1-9/100000 (Europe); Age of onset: Neonatal; Age of death: normal life expectancy;

OMIM:

57
Inheritance:
autosomal dominant


HPO:

32
van der woude syndrome 1:
Inheritance autosomal dominant inheritance


Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Fetal diseases
See all MalaCards categories (disease lists)
ICD10: 33 34
Orphanet: 59  
Developmental anomalies during embryogenesis


External Ids:

OMIM 57 119300
Disease Ontology 12 DOID:0060239
ICD10 33 Q38.0
NCIt 50 C74986
SNOMED-CT 68 79261008
Orphanet 59 ORPHA888
UMLS via Orphanet 74 C0175697
ICD10 via Orphanet 34 Q38.0
MESH via Orphanet 45 C536528
MedGen 42 C0175697
Sources

Summaries for Van Der Woude Syndrome 1

About this section
NIH Rare Diseases : 53 Van der Woude syndrome is a condition that affects the development of the face. Many people with this disorder are born with a cleft lip and/or a cleft palate. Affected individuals usually have depressions (pits) near the center of the lower lip, which may appear moist due to the presence of salivary and mucous glands in the pits. Small mounds of tissue on the lower lip may also occur. In some cases, people with van der Woude syndrome have missing teeth. Growth and intelligence are usually normal. This condition is caused by mutations in the IRF6 gene and is inherited in a autosomal dominant fashion. Van der Woude syndrome represents the mild end of the spectrum of disorders known as IRF6-related disorders. At the more severe end of the spectrum is popliteal pterygium syndrome.

MalaCards based summary : Van Der Woude Syndrome 1, also known as van der woude syndrome, is related to van der woude syndrome 2 and nemaline myopathy 3. An important gene associated with Van Der Woude Syndrome 1 is IRF6 (Interferon Regulatory Factor 6), and among its related pathways/superpathways are Signaling by Robo receptor and Signaling by Slit. The drugs Dopamine and Adalimumab have been mentioned in the context of this disorder. Affiliated tissues include heart, salivary gland and brain, and related phenotypes are cleft palate and lower lip pit

Disease Ontology : 12 A syndrome characterized by the combination of lower lip pits, cleft lip with or without cleft palate and cleft palate alone.

Genetics Home Reference : 25 Van der Woude syndrome is a condition that affects the development of the face. Many people with this disorder are born with a cleft lip, a cleft palate (an opening in the roof of the mouth), or both. Affected individuals usually have depressions (pits) near the center of the lower lip, which may appear moist due to the presence of salivary and mucous glands in the pits. Small mounds of tissue on the lower lip may also occur. In some cases, people with van der Woude syndrome have missing teeth.

OMIM : 57 Van der Woude syndrome (VWS) is a dominantly inherited developmental disorder characterized by pits and/or sinuses of the lower lip, and cleft lip and/or cleft palate (CL/P, CP). It is the most common cleft syndrome. (119300)

UniProtKB/Swiss-Prot : 75 Van der Woude syndrome 1: An autosomal dominant developmental disorder characterized by lower lip pits, cleft lip and/or cleft palate.

Wikipedia : 76 Van der Woude syndrome (VDWS) is a genetic disorder characterized by the combination of lower lip pits,... more...

Sources

Related Diseases for Van Der Woude Syndrome 1

About this section

Diseases related to Van Der Woude Syndrome 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 231)
# Related Disease Score Top Affiliating Genes
1 van der woude syndrome 2 32.0 CFAP57 GRHL3
2 nemaline myopathy 3 12.3
3 hypertelorism, preauricular sinus, punctal pits, and deafness 12.2
4 ear pits, posterior helical 12.1
5 annular lichen planus 11.9
6 annular atrophic lichen planus 11.7
7 actinic lichen planus 11.7
8 atrophic lichen planus 11.7
9 rare lichen planus 11.6
10 lichen planus pemphigoides 11.3
11 lipoid proteinosis of urbach and wiethe 11.3
12 lichen planus 11.2
13 lrba deficiency 11.2
14 lichen planus pigmentosus 11.1
15 linear lichen planus 11.1
16 irf6-related disorders 11.1
17 ehlers-danlos syndrome, kyphoscoliotic type, 2 10.8
18 hellp syndrome 10.8
19 vulvovaginal gingival syndrome 10.8
20 endotheliitis 10.4
21 alcoholic hepatitis 10.4
22 chromosome 1q21.1 deletion syndrome, 1.35-mb 10.3 IRF6 RIPK4
23 hepatitis 10.2
24 peritonitis 10.1
25 neuronitis 10.1
26 periodontitis 10.1
27 orofacial cleft 10.0 GRHL3 IRF6 SATB2
28 aging 10.0
29 infantile liver failure syndrome 1 10.0
30 acute liver failure 9.9
31 arthritis 9.9
32 cleft palate, isolated 9.9 GRHL3 IRF6 SATB2
33 hemifacial microsomia 9.9 BRF1 SATB2
34 myocardial infarction 9.9
35 astrocytoma 9.9
36 gingivitis 9.9
37 commissural lip pits 9.9
38 diabetes mellitus 9.9
39 mastitis 9.9
40 cocoon syndrome 9.9 GRHL3 IRF6 RIPK4
41 physical disorder 9.9 IRF6 SATB2
42 hypercholesterolemia, familial 9.9
43 asthma 9.9
44 autoimmune hepatitis 9.9
45 cerebritis 9.9
46 pancreatitis 9.9
47 pneumonia 9.9
48 chromosome 3pter-p25 deletion syndrome 9.8 SRGAP2 SRGAP3
49 adult syndrome 9.8 BRF1 SATB2
50 crohn's disease 9.8

Graphical network of the top 20 diseases related to Van Der Woude Syndrome 1:



Diseases related to Van Der Woude Syndrome 1
Sources

Symptoms & Phenotypes for Van Der Woude Syndrome 1

About this section

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Mouth:
cleft palate
cleft lip
lower lip pits
cleft uvula

Head And Neck Teeth:
hypodontia


Clinical features from OMIM:

119300

Human phenotypes related to Van Der Woude Syndrome 1:

59 32 (show all 8)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 cleft palate 59 32 frequent (33%) Frequent (79-30%) HP:0000175
2 lower lip pit 59 32 frequent (33%) Frequent (79-30%) HP:0000196
3 cleft upper lip 59 32 occasional (7.5%) Occasional (29-5%) HP:0000204
4 hypodontia 59 32 occasional (7.5%) Occasional (29-5%) HP:0000668
5 abnormality of the salivary glands 59 Occasional (29-5%)
6 lip pit 59 Very frequent (99-80%)
7 bifid uvula 32 HP:0000193
8 abnormal salivary gland morphology 32 occasional (7.5%) HP:0010286

MGI Mouse Phenotypes related to Van Der Woude Syndrome 1:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 limbs/digits/tail MP:0005371 9.02 CNTN2 GRHL3 IRF6 RIPK4 SATB2
Sources

Drugs & Therapeutics for Van Der Woude Syndrome 1

About this section

Drugs for Van Der Woude Syndrome 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
2
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
3 Vedolizumab Approved Phase 4 943609-66-3
4 Autonomic Agents Phase 4
5 Dopamine Agents Phase 4
6 Neurotransmitter Agents Phase 4
7 Peripheral Nervous System Agents Phase 4
8 Protective Agents Phase 4
9 Anti-Inflammatory Agents Phase 4,Phase 3
10 Antirheumatic Agents Phase 4,Phase 3
11 Gastrointestinal Agents Phase 4
12 Antibodies Phase 4
13 Immunoglobulins Phase 4
14 Immunosuppressive Agents Phase 4
15
Ciprofloxacin Approved, Investigational Phase 3 85721-33-1 2764
16 Anti-Bacterial Agents Phase 3
17 Anti-Infective Agents Phase 3
18 Cytochrome P-450 CYP1A2 Inhibitors Phase 3
19 Cytochrome P-450 Enzyme Inhibitors Phase 3
20 Topoisomerase Inhibitors Phase 3
21
Paclitaxel Approved, Vet_approved Phase 1, Phase 2 33069-62-4 36314
22 Muromonab-CD3 Phase 1, Phase 2
23 Albumin-Bound Paclitaxel Phase 1, Phase 2
24 Antimitotic Agents Phase 1, Phase 2
25 Antineoplastic Agents, Phytogenic Phase 1, Phase 2
26
Oxaliplatin Approved, Investigational Phase 1 61825-94-3 5310940 9887054 43805 6857599
27
s 1 (combination) Phase 1
28
Infliximab Approved 170277-31-3
29 Dermatologic Agents

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Donor Dopamine and Initial Graft Function Completed NCT00115115 Phase 4 Dopamine infusion to brain dead organ donors
2 Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients Recruiting NCT03172377 Phase 4
3 An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis Recruiting NCT02646657 Phase 4 Vedolizumab 300 mg
4 A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study Recruiting NCT02646683 Phase 4 vedolizumab
5 Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's Completed NCT00736983 Phase 3 adalimumab;ciprofloxacin
6 NI-0401 in Active Crohn's Disease Completed NCT00630643 Phase 1, Phase 2 Placebo
7 A Pilot Study of FFP104 in Subjects With Crohn's Disease Recruiting NCT02465944 Phase 1, Phase 2 FFP104;Placebo
8 Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma Recruiting NCT02406170 Phase 1, Phase 2 Regorafenib;Paclitaxel
9 Feasibility Study of Adjuvant Treatment With S-1 and Oxaliplatin in Patients With Resectable Esophageal Cancer Recruiting NCT02347904 Phase 1 S-1 and Oxaliplatin
10 Biomarkers of Anti-TNF Treatment in IBD Completed NCT01971970

Search NIH Clinical Center for Van Der Woude Syndrome 1

Cochrane evidence based reviews: myopathy, actin, congenital, with excess of thin myofilaments

Sources

Genetic Tests for Van Der Woude Syndrome 1

About this section

Genetic tests related to Van Der Woude Syndrome 1:

# Genetic test Affiliating Genes
1 Van Der Woude Syndrome 29 IRF6
2 Lip Pit 29
Sources

Anatomical Context for Van Der Woude Syndrome 1

About this section

MalaCards organs/tissues related to Van Der Woude Syndrome 1:

41
Heart, Salivary Gland, Brain, Testes
Sources

Publications for Van Der Woude Syndrome 1

About this section

Articles related to Van Der Woude Syndrome 1:

(show top 50) (show all 149)
# Title Authors Year
1
Treatment of lower lip pits in Van der Woude syndrome: a systematic review. ( 29089202 )
2018
2
Concurrent Van der Woude syndrome and Turner syndrome: A case report. ( 28228961 )
2017
3
Surgical management of lower lip pits in Van der Woude syndrome. ( 28893716 )
2017
4
Van der Woude syndrome presenting as a single median lower lip pit with associated dental, orofacial and limb deformities: a rare case report. ( 28875142 )
2017
5
A Novel Interferon Regulatory Factor 6 Mutation in an Asian Family With Van der Woude Syndrome. ( 27243668 )
2016
6
Interferon Regulatory Factor 6 Controls Proliferation of Keratinocytes From Children With Van der Woude Syndrome. ( 27115562 )
2016
7
Association study between Van der Woude Syndrome causative gene GRHL3 and nonsyndromic cleft lip with or without cleft palate in a Chinese cohort. ( 27129939 )
2016
8
Multidisciplinary management of a patient with van der Woude syndrome: A case report. ( 28012331 )
2016
9
Management of Lip Pits in Van der Woude Syndrome: A Clinical Classification With Difficulty Index. ( 27321409 )
2016
10
Craniofacial morphology in children with van der Woude syndrome and isolated cleft palate. ( 25516228 )
2014
11
Van der Woude syndrome: a review of 11 cases seen at the Lagos University Teaching Hospital. ( 24647295 )
2014
12
Van der woude syndrome (lip pit-cleft lip syndrome). ( 24461788 )
2014
13
Novel IRF6 mutations in families with Van Der Woude syndrome and popliteal pterygium syndrome from sub-Saharan Africa. ( 24936515 )
2014
14
Dominant Mutations in GRHL3 Cause Van der Woude Syndrome and Disrupt Oral Periderm Development. ( 24360809 )
2014
15
Genome-wide copy number scan identifies IRF6 involvement in Van der Woude syndrome in an Indian family. ( 25579819 )
2014
16
Van der woude syndrome with short review of the literature. ( 25050184 )
2014
17
Van der Woude syndrome: Management in the mixed dentition. ( 23853466 )
2013
18
Novel lip pit phenotypes and mutations of IRF6 in Van der Woude syndrome patients from Pakistan. ( 23713753 )
2013
19
Comparative analysis of IRF6 variants in families with Van der Woude syndrome and popliteal pterygium syndrome using public whole-exome databases. ( 23154523 )
2013
20
De novo 2.3 Mb microdeletion of 1q32.2 involving the Van der Woude Syndrome locus. ( 23915469 )
2013
21
Inverted-T lip reduction for lower lip repair in Van der Woude syndrome: a review and comparison of aesthetic results. ( 23290085 )
2013
22
Congenital lower lip pits (van der Woude syndrome): what pathologists need to know. ( 23947719 )
2013
23
Van der Woude syndrome: report of two cases with supplementary findings. ( 24025891 )
2013
24
An alternative technique using a gutta percha points and blue methylene to excision of congenital fistula of lower lip in patient with Van der Woude syndrome. ( 23037784 )
2012
25
A novel mutation in the IRF6 gene associated with facial asymmetry in a family affected with Van der Woude syndrome. ( 21995291 )
2012
26
Van der Woude syndrome- a syndromic form of orofacial clefting. ( 24558537 )
2012
27
Van der woude syndrome associated with hypodontia: a rare clinical entity. ( 23326687 )
2012
28
Van der Woude syndrome with an unusual intraoral finding. ( 21525698 )
2011
29
Genomic strategy identifies a missense mutation in WD-repeat domain 65 (WDR65) in an individual with Van der Woude syndrome. ( 21574244 )
2011
30
Monozygotic twins with variable expression of Van der Woude syndrome. ( 21739575 )
2011
31
IRF6 mutations may not be a major cause of Van der Woude syndrome in India. ( 20845047 )
2011
32
Oral and maxillofacial pathology. Case of the month. Van der Woude syndrome (VWS). ( 21957792 )
2011
33
Novel IRF6 mutations in Honduran Van der Woude syndrome patients. ( 21468557 )
2011
34
Symmetric lower lip pits - Van Der Woude syndrome. ( 21999450 )
2011
35
Identification of a Van der Woude syndrome mutation in the cleft palate 1 mutant mouse. ( 20196077 )
2010
36
Wound complications after cleft repair in children with Van der Woude syndrome. ( 20856020 )
2010
37
A heritable cause of cleft lip and palate--Van der Woude syndrome caused by a novel IRF6 mutation. Review of the literature and of the differential diagnosis. ( 19536562 )
2010
38
The role of 9qh+ in phenotypic and genotypic heterogeneity in a Van der Woude syndrome pedigree. ( 20660977 )
2010
39
Highlighted article: "identification of a Van der Woude syndrome mutation in the cleft palate 1 mutant mouse" by Stottmann, Bjork, Doyle, and Beier. ( 20461822 )
2010
40
Van der Woude syndrome: dentofacial features and implications for clinical practice. ( 20415912 )
2010
41
Two novel mutations affecting splicing in the IRF6 gene associated with van der Woude syndrome. ( 20856073 )
2010
42
Lower lip pits in a patient with van der Woude syndrome. ( 20818247 )
2010
43
Epidemiology of Van der Woude syndrome from mutational analyses in affected patients from Pakistan. ( 20184620 )
2010
44
Isolated lower lip fistulas in Van der Woude syndrome. ( 19816310 )
2009
45
Coding region of IRF6 gene may not be causal for Van der Woude syndrome in cases from India. ( 19929101 )
2009
46
Variable phenotypic manifestation of IRF6 mutations in the Van der Woude syndrome and popliteal pterygium syndrome: implications for genetic counseling. ( 19623037 )
2009
47
Three novel mutations of the IRF6 gene with one associated with an unusual feature in Van der Woude syndrome. ( 19842205 )
2009
48
Missense mutations that cause Van der Woude syndrome and popliteal pterygium syndrome affect the DNA-binding and transcriptional activation functions of IRF6. ( 19036739 )
2009
49
Prevalence and nonrandom distribution of exonic mutations in interferon regulatory factor 6 in 307 families with Van der Woude syndrome and 37 families with popliteal pterygium syndrome. ( 19282774 )
2009
50
Reconstruction of the lower lip in Van der Woude syndrome. ( 19325355 )
2009
Sources

Variations for Van Der Woude Syndrome 1

About this section

UniProtKB/Swiss-Prot genetic disease variations for Van Der Woude Syndrome 1:

75 (show all 34)
# Symbol AA change Variation ID SNP ID
1 IRF6 p.Ala2Val VAR_014961 rs28942093
2 IRF6 p.Val18Ala VAR_014962
3 IRF6 p.Val18Met VAR_014963
4 IRF6 p.Pro39Ala VAR_014964
5 IRF6 p.Ala61Gly VAR_014966
6 IRF6 p.Gly70Arg VAR_014968 rs776236749
7 IRF6 p.Pro76Ser VAR_014969 rs886039388
8 IRF6 p.Asn88His VAR_014973
9 IRF6 p.Ser90Gly VAR_014975
10 IRF6 p.Asp98His VAR_014976
11 IRF6 p.Arg250Gln VAR_014977
12 IRF6 p.Gln273Arg VAR_014978
13 IRF6 p.Leu294Pro VAR_014981
14 IRF6 p.Val297Ile VAR_014982
15 IRF6 p.Lys320Glu VAR_014983
16 IRF6 p.Val321Met VAR_014984
17 IRF6 p.Gly325Glu VAR_014985
18 IRF6 p.Leu345Pro VAR_014986
19 IRF6 p.Cys347Phe VAR_014987
20 IRF6 p.Phe369Ser VAR_014988
21 IRF6 p.Cys374Trp VAR_014989
22 IRF6 p.Lys388Glu VAR_014990
23 IRF6 p.Arg6Cys VAR_030046 rs28942094
24 IRF6 p.Ala16Val VAR_030047
25 IRF6 p.Leu22Pro VAR_030048 rs387906967
26 IRF6 p.Arg45Gln VAR_030049 rs121434229
27 IRF6 p.Thr64Ile VAR_030050
28 IRF6 p.Arg84Gly VAR_030051
29 IRF6 p.Thr100Ala VAR_030052
30 IRF6 p.Leu251Pro VAR_030053
31 IRF6 p.Glu349Val VAR_030054
32 IRF6 p.Pro396Ser VAR_030055 rs121434230
33 IRF6 p.Arg400Trp VAR_030056 rs28942095
34 IRF6 p.Arg339Ile VAR_059080 rs121434231

ClinVar genetic disease variations for Van Der Woude Syndrome 1:

6
(show top 50) (show all 183)
# Gene Variation Type Significance SNP ID Assembly Location
1 IRF6 NM_006147.3(IRF6): c.274G> T (p.Glu92Ter) single nucleotide variant Pathogenic rs121434224 GRCh37 Chromosome 1, 209969798: 209969798
2 IRF6 NM_006147.3(IRF6): c.274G> T (p.Glu92Ter) single nucleotide variant Pathogenic rs121434224 GRCh38 Chromosome 1, 209796453: 209796453
3 IRF6 NM_006147.3(IRF6): c.870_888del19insA (p.Phe290_Asp296delinsLeu) indel Pathogenic rs587776569 GRCh37 Chromosome 1, 209964012: 209964030
4 IRF6 NM_006147.3(IRF6): c.870_888del19insA (p.Phe290_Asp296delinsLeu) indel Pathogenic rs587776569 GRCh38 Chromosome 1, 209790667: 209790685
5 IRF6 NM_006147.3(IRF6): c.5C> T (p.Ala2Val) single nucleotide variant Pathogenic rs28942093 GRCh37 Chromosome 1, 209974754: 209974754
6 IRF6 NM_006147.3(IRF6): c.5C> T (p.Ala2Val) single nucleotide variant Pathogenic rs28942093 GRCh38 Chromosome 1, 209801409: 209801409
7 IRF6 NM_006147.3(IRF6): c.16C> T (p.Arg6Cys) single nucleotide variant Pathogenic/Likely pathogenic rs28942094 GRCh37 Chromosome 1, 209974743: 209974743
8 IRF6 NM_006147.3(IRF6): c.16C> T (p.Arg6Cys) single nucleotide variant Pathogenic/Likely pathogenic rs28942094 GRCh38 Chromosome 1, 209801398: 209801398
9 IRF6 NM_006147.3(IRF6): c.1137G> A (p.Trp379Ter) single nucleotide variant Pathogenic rs121434228 GRCh37 Chromosome 1, 209963054: 209963054
10 IRF6 NM_006147.3(IRF6): c.1137G> A (p.Trp379Ter) single nucleotide variant Pathogenic rs121434228 GRCh38 Chromosome 1, 209789709: 209789709
11 IRF6 NM_006147.3(IRF6): c.1198C> T (p.Arg400Trp) single nucleotide variant Pathogenic rs28942095 GRCh37 Chromosome 1, 209961971: 209961971
12 IRF6 NM_006147.3(IRF6): c.1198C> T (p.Arg400Trp) single nucleotide variant Pathogenic rs28942095 GRCh38 Chromosome 1, 209788626: 209788626
13 IRF6 NC_000001.11: g.209782473_209799634del17162 deletion Pathogenic GRCh38 Chromosome 1, 209782473: 209799634
14 IRF6 NM_006147.3(IRF6): c.134G> A (p.Arg45Gln) single nucleotide variant Pathogenic rs121434229 GRCh37 Chromosome 1, 209974625: 209974625
15 IRF6 NM_006147.3(IRF6): c.134G> A (p.Arg45Gln) single nucleotide variant Pathogenic rs121434229 GRCh38 Chromosome 1, 209801280: 209801280
16 IRF6 NM_006147.3(IRF6): c.1186C> T (p.Pro396Ser) single nucleotide variant Pathogenic rs121434230 GRCh37 Chromosome 1, 209961983: 209961983
17 IRF6 NM_006147.3(IRF6): c.1186C> T (p.Pro396Ser) single nucleotide variant Pathogenic rs121434230 GRCh38 Chromosome 1, 209788638: 209788638
18 IRF6 NM_006147.3(IRF6): c.1016G> T (p.Arg339Ile) single nucleotide variant Pathogenic rs121434231 GRCh37 Chromosome 1, 209963884: 209963884
19 IRF6 NM_006147.3(IRF6): c.1016G> T (p.Arg339Ile) single nucleotide variant Pathogenic rs121434231 GRCh38 Chromosome 1, 209790539: 209790539
20 IRF6 NM_006147.3(IRF6): c.65T> C (p.Leu22Pro) single nucleotide variant Pathogenic rs387906967 GRCh37 Chromosome 1, 209974694: 209974694
21 IRF6 NM_006147.3(IRF6): c.65T> C (p.Leu22Pro) single nucleotide variant Pathogenic rs387906967 GRCh38 Chromosome 1, 209801349: 209801349
22 IRF6 NM_006147.3(IRF6): c.145C> T (p.Gln49Ter) single nucleotide variant Pathogenic rs397515434 GRCh37 Chromosome 1, 209974614: 209974614
23 IRF6 NM_006147.3(IRF6): c.145C> T (p.Gln49Ter) single nucleotide variant Pathogenic rs397515434 GRCh38 Chromosome 1, 209801269: 209801269
24 IRF6 NM_006147.3(IRF6): c.1199G> A (p.Arg400Gln) single nucleotide variant Pathogenic rs200166664 GRCh37 Chromosome 1, 209961970: 209961970
25 IRF6 NM_006147.3(IRF6): c.1199G> A (p.Arg400Gln) single nucleotide variant Pathogenic rs200166664 GRCh38 Chromosome 1, 209788625: 209788625
26 IRF6 NM_006147.3(IRF6): c.1210G> A (p.Glu404Lys) single nucleotide variant Conflicting interpretations of pathogenicity rs769068305 GRCh37 Chromosome 1, 209961959: 209961959
27 IRF6 NM_006147.3(IRF6): c.1210G> A (p.Glu404Lys) single nucleotide variant Conflicting interpretations of pathogenicity rs769068305 GRCh38 Chromosome 1, 209788614: 209788614
28 IRF6 NM_006147.3(IRF6): c.1153T> C (p.Leu385=) single nucleotide variant Benign rs61099902 GRCh37 Chromosome 1, 209963038: 209963038
29 IRF6 NM_006147.3(IRF6): c.1153T> C (p.Leu385=) single nucleotide variant Benign rs61099902 GRCh38 Chromosome 1, 209789693: 209789693
30 IRF6 NM_006147.3(IRF6): c.820G> A (p.Val274Ile) single nucleotide variant Benign rs2235371 GRCh37 Chromosome 1, 209964080: 209964080
31 IRF6 NM_006147.3(IRF6): c.820G> A (p.Val274Ile) single nucleotide variant Benign rs2235371 GRCh38 Chromosome 1, 209790735: 209790735
32 IRF6 NM_006147.3(IRF6): c.759T> C (p.Tyr253=) single nucleotide variant Likely benign rs41303263 GRCh37 Chromosome 1, 209964141: 209964141
33 IRF6 NM_006147.3(IRF6): c.759T> C (p.Tyr253=) single nucleotide variant Likely benign rs41303263 GRCh38 Chromosome 1, 209790796: 209790796
34 IRF6 NM_006147.3(IRF6): c.459G> T (p.Ser153=) single nucleotide variant Benign rs2013162 GRCh37 Chromosome 1, 209968684: 209968684
35 IRF6 NM_006147.3(IRF6): c.459G> T (p.Ser153=) single nucleotide variant Benign rs2013162 GRCh38 Chromosome 1, 209795339: 209795339
36 IRF6 NM_006147.3(IRF6): c.175-5C> G single nucleotide variant Benign rs7552506 GRCh37 Chromosome 1, 209969902: 209969902
37 IRF6 NM_006147.3(IRF6): c.175-5C> G single nucleotide variant Benign rs7552506 GRCh38 Chromosome 1, 209796557: 209796557
38 IRF6 NM_006147.3(IRF6): c.226C> T (p.Pro76Ser) single nucleotide variant Pathogenic/Likely pathogenic rs886039388 GRCh37 Chromosome 1, 209969846: 209969846
39 IRF6 NM_006147.3(IRF6): c.226C> T (p.Pro76Ser) single nucleotide variant Pathogenic/Likely pathogenic rs886039388 GRCh38 Chromosome 1, 209796501: 209796501
40 IRF6 NM_006147.3(IRF6): c.*2472G> A single nucleotide variant Likely benign rs188593210 GRCh38 Chromosome 1, 209785948: 209785948
41 IRF6 NM_006147.3(IRF6): c.*2472G> A single nucleotide variant Likely benign rs188593210 GRCh37 Chromosome 1, 209959293: 209959293
42 IRF6 NM_006147.3(IRF6): c.*1678delT deletion Benign rs141112353 GRCh37 Chromosome 1, 209960087: 209960087
43 IRF6 NM_006147.3(IRF6): c.*1678delT deletion Benign rs141112353 GRCh38 Chromosome 1, 209786742: 209786742
44 IRF6 NM_006147.3(IRF6): c.*1473C> G single nucleotide variant Likely benign rs531092939 GRCh37 Chromosome 1, 209960292: 209960292
45 IRF6 NM_006147.3(IRF6): c.*1473C> G single nucleotide variant Likely benign rs531092939 GRCh38 Chromosome 1, 209786947: 209786947
46 IRF6 NM_006147.3(IRF6): c.*1265G> C single nucleotide variant Likely benign rs149425923 GRCh37 Chromosome 1, 209960500: 209960500
47 IRF6 NM_006147.3(IRF6): c.*1265G> C single nucleotide variant Likely benign rs149425923 GRCh38 Chromosome 1, 209787155: 209787155
48 IRF6 NM_006147.3(IRF6): c.*342A> C single nucleotide variant Likely benign rs146078290 GRCh38 Chromosome 1, 209788078: 209788078
49 IRF6 NM_006147.3(IRF6): c.*342A> C single nucleotide variant Likely benign rs146078290 GRCh37 Chromosome 1, 209961423: 209961423
50 IRF6 NM_006147.3(IRF6): c.*204C> T single nucleotide variant Likely benign rs77906982 GRCh38 Chromosome 1, 209788216: 209788216

Copy number variations for Van Der Woude Syndrome 1 from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 26163 1 197500000 222100000 Microdeletion van der Woude syndrome
2 26164 1 197500000 222100000 Microdeletion IRF6 van der Woude syndrome
Sources

Expression for Van Der Woude Syndrome 1

About this section
Search GEO for disease gene expression data for Van Der Woude Syndrome 1.
Sources

Pathways for Van Der Woude Syndrome 1

About this section

Pathways related to Van Der Woude Syndrome 1 according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Signaling by Robo receptor 66
Show member pathways
 10.8 SRGAP2 SRGAP3
2
Signaling by Slit 64
10.3 SRGAP2 SRGAP3
Sources

GO Terms for Van Der Woude Syndrome 1

About this section

Biological processes related to Van Der Woude Syndrome 1 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 interferon-gamma-mediated signaling pathway GO:0060333 8.96 IRF6 TRIM8
2 positive regulation of GTPase activity GO:0043547 8.8 GRHL3 SRGAP2 SRGAP3

Molecular functions related to Van Der Woude Syndrome 1 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 Rac GTPase binding GO:0048365 8.62 SRGAP2 SRGAP3
Sources

Sources for Van Der Woude Syndrome 1

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....